Harmony Biosciences Holdings Inc (HRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 549,769 | 589,398 | 752,502 | 646,999 | 546,050 |
| Marketable Securities | 118,022 | 51,520 | 22,838 | 25,582 | 19,224 |
| Receivables | 110,995 | 108,222 | 96,787 | 100,651 | 92,981 |
| Inventories | 6,360 | 5,281 | 5,357 | 6,882 | 6,100 |
| Other current assets | 9,877 | 7,595 | 13,516 | 35,378 | 8,636 |
| TOTAL | $814,334 | $778,817 | $907,014 | $838,800 | $691,354 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 1,440 | 1,376 |
| Investments And Advances | 294,668 | 229,555 | 107,127 | 105,831 | 107,008 |
| Intangibles | 77,496 | 83,457 | 89,418 | 95,380 | 101,341 |
| Other Non-Current Assets | 186,586 | 179,995 | 168,072 | 166,767 | 206,929 |
| TOTAL | $558,750 | $493,007 | $364,617 | $369,418 | $416,654 |
| Total Assets | $1,373,084 | $1,271,824 | $1,271,631 | $1,208,218 | $1,108,008 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20,000 | 20,000 | 20,000 | 20,000 | 18,750 |
| Accounts payable and accrued liabilities | 21,684 | 28,600 | 17,693 | 26,341 | 28,301 |
| Accrued Expenses | 181,219 | 156,833 | 209,482 | 176,237 | 130,028 |
| Other current liabilities | 11,167 | 11,907 | 4,957 | 825 | 3,056 |
| TOTAL | $234,070 | $217,340 | $252,132 | $223,403 | $180,135 |
| Non-Current Liabilities | |||||
| Long Term Debt | 133,961 | 138,814 | 143,663 | 148,506 | 153,345 |
| Other Non-Current Liabilities | 5,810 | 5,321 | 5,618 | 1,186 | 1,448 |
| TOTAL | $139,771 | $144,135 | $149,281 | $149,692 | $154,793 |
| Total Liabilities | $373,841 | $361,475 | $401,413 | $373,095 | $334,928 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,236 | 57,893 | 57,841 | 57,596 | 57,533 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | 268,822 | 193,391 | 160,903 | 138,417 | 87,552 |
| Other shareholders' equity | -727 | -413 | 346 | 357 | 239 |
| TOTAL | $999,243 | $910,349 | $870,218 | $835,123 | $773,080 |
| Total Liabilities And Equity | $1,373,084 | $1,271,824 | $1,271,631 | $1,208,218 | $1,108,008 |